A yeast screening method to decipher the interaction between the adenosine A2B receptor and the C-terminus of different G protein α-subunits

Purinergic Signalling

Volumn 10, Issue 3, 2014, Pages 441-453

  Liu, Rongfang ^a   Groenewoud, Nick J A ^a   Peeters, Miriam C ^a   Lenselink, Eelke B ^a   IJzerman, Ad P ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Adenosine A2B receptor; DRY motif; G protein coupling; G protein coupled receptor; Yeast screening

Indexed keywords

ADENOSINE A2B RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; PROTEIN BINDING;

AMINO ACID SEQUENCE; CHEMISTRY; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; PROTEIN SECONDARY STRUCTURE; SACCHAROMYCES CEREVISIAE;

AMINO ACID SEQUENCE; GTP-BINDING PROTEIN ALPHA SUBUNITS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; RECEPTOR, ADENOSINE A2B; SACCHAROMYCES CEREVISIAE;

EID: 84892754308     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-014-9407-6     Document Type: Article

References (49)

1. Oldham WM, Van Eps N, Preininger AM, Hubbell WL, Hamm HE (2006) Mechanism of the receptor-catalyzed activation of heterotrimeric G proteins. Nature structural & molecular biology 13(9):772–777
2. Baltoumas FA, Theodoropoulou MC, Hamodrakas SJ (2013) Interactions of the alpha-subunits of heterotrimeric G-proteins with GPCRs, effectors and RGS proteins: a critical review and analysis of interacting surfaces, conformational shifts, structural diversity and electrostatic potentials. Journal of structural biology 182(3):209–218
3. Fredholm BB, Arslan G, Halldner L, Kull B, Schulte G, Wasserman W (2000) Structure and function of adenosine receptors and their genes. Naunyn-Schmiedeberg’s archives of pharmacology 362(4–5):364–374
4. Fredholm BB, Irenius E, Kull B, Schulte G (2001) Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem Pharmacol 61(4):443–448
5. Wei W, Du C, Lv J, Zhao G, Li Z, Wu Z, Haskó G, Xie X (2013) Blocking A2B adenosine receptor alleviates pathogenesis of experimental autoimmune encephalomyelitis via inhibition of IL-6 production and Th17 differentiation. The Journal of Immunology 190(1):138–146
6. Wei Q, Costanzi S, Balasubramanian R, Gao Z-G, Jacobson KA (2013) A2B adenosine receptor blockade inhibits growth of prostate cancer cells. Purinergic signalling: 1–10
7. Stagg J, Divisekera U, McLaughlin N, Sharkey J, Pommey S, Denoyer D, Dwyer KM, Smyth MJ (2010) Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. Proc Natl Acad Sci 107(4):1547–1552
8. Owen SJ, Massa HH, Rose’Meyer RB (2012) Loss of adenosine A2B receptor mediated relaxant responses in the aged female rat bladder; effects of dietary phytoestrogens. Naunyn-Schmiedeberg’s archives of pharmacology 385(5):539–549
9. Cekic C, Sag D, Li Y, Theodorescu D, Strieter RM, Linden J (2012) Adenosine A2B receptor blockade slows growth of bladder and breast tumors. The Journal of Immunology 188(1):198–205
10. Koscsó B, Trepakov A, Csóka B, Németh ZH, Pacher P, Eltzschig HK, Haskó G (2013) Stimulation of A2B adenosine receptors protects against trauma–hemorrhagic shock-induced lung injury. Purinergic signalling: 1–6
11. Bot I, De Vries H, Korporaal SJ, Foks AC, Bot M, Van Veldhoven J, Ter Borg MN, Van Santbrink PJ, Van Berkel TJ, Kuiper J, IJzerman AP (2012) Adenosine A2B receptor agonism inhibits neointimal lesion development after arterial injury in apolipoprotein E-deficient mice. Arteriosclerosis, thrombosis, and vascular biology 32(9):2197–2205
12. Pausch MH (1997) G-protein-coupled receptors in Saccharomyces cerevisiae: high-throughput screening assays for drug discovery. Trends in biotechnology 15(12):487–494
13. Peeters MC, Li Q, van Westen GJP, IJzerman AP (2011) Three “hotspots” important for adenosine A 2B receptor activation: a mutational analysis of transmembrane domains 4 and 5 and the second extracellular loop. Purinergic Signalling:1–16
14. Mathew E, Ding F-X, Naider F, Dumont ME (2013) Functional fusions of T4 lysozyme in the third intracellular loop of a G protein-coupled receptor identified by a random screening approach in yeast. Protein Engineering Design and Selection 26(1):59–71
15. Jaeschke H, Kleinau G, Sontheimer J, Mueller S, Krause G, Paschke R (2008) Preferences of transmembrane helices for cooperative amplification of G α s and G α q signaling of the thyrotropin receptor. Cellular and molecular life sciences 65(24):4028–4038
16. Evans BJ, Wang Z, Broach JR, Oishi S, Fujii N, Peiper SC (2009) Expression of CXCR4, a G-protein-coupled receptor for CXCL12 in yeast: identification of new-generation inverse agonists. Methods in enzymology 460:399–412
17. Minic J, Sautel M, Salesse R, Pajot-Augy E (2005) Yeast system as a screening tool for pharmacological assessment of G protein coupled receptors. Current medicinal chemistry 12(8):961–969
18. Stewart GD, Valant C, Dowell SJ, Mijaljica D, Devenish RJ, Scammells PJ, Sexton PM, Christopoulos A (2009) Determination of adenosine A1 receptor agonist and antagonist pharmacology using Saccharomyces cerevisiae: implications for ligand screening and functional selectivity. Journal of Pharmacology and Experimental Therapeutics 331(1):277–286
19. Brown AJ, Dyos SL, Whiteway MS, White JH, Watson MAE, Marzioch M, Clare JJ, Cousens DJ, Paddon C, Plumpton C (2000) Functional coupling of mammalian receptors to the yeast mating pathway using novel yeast/mammalian G protein α subunit chimeras. Yeast 16(1):11–22
20. Dowell SJ, Brown AJ (2009) Yeast assays for G protein-coupled receptors. G Protein-Coupled Receptors in Drug Discovery 552:213–229
21. Dowell SJ (2002) Yeast assays for G-protein-coupled receptors. receptors and channels 8(343–352)
22. Cardozo T, Totrov M, Abagyan R (2004) Homology modeling by the ICM method. Proteins: Structure, Function, and Bioinformatics 23(3):403–414
23. s protein complex. Nature 477(7366):549–555
24. DeLano DW (The PyMOL Molecular Graphics System, Version 1.5. 0.4 Schrödinger, LLC.)
25. Gietz D, St Jean A, Woods RA, Schiestl RH (1992) Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res 20(6):1425
26. Li Q, Ye K, Blad CC, den Dulk H, Brouwer J, IJzerman AP, Beukers MW (2007) ZM241385, DPCPX, MRS1706 are inverse agonists with different relative intrinsic efficacies on constitutively active mutants of the human adenosine A2B receptor. Journal of Pharmacology and Experimental Therapeutics 320(2):637–645
27. Feoktistov I, Goldstein A, Sheller JR, Schwartz LB, Biaggioni I (2003) Immunological characterization of A2B adenosine receptors in human mast cells. Drug development research 58(4):461–471
28. Peeters M, Wisse L, Dinaj A, Vroling B, Vriend G, IJzerman A (2012) The role of the second and third extracellular loops of the adenosine A1 receptor in activation and allosteric modulation. Biochem Pharmacol 84:76–87
29. Venkatakrishnan A, Deupi X, Lebon G, Tate CG, Schertler GF, Babu MM (2013) Molecular signatures of G-protein-coupled receptors. Nature 494(7436):185–194
30. Scheerer P, Park JH, Hildebrand PW, Kim YJ, Krauß N, Choe H-W, Hofmann KP, Ernst OP (2008) Crystal structure of opsin in its G-protein-interacting conformation. Nature 455(7212):497–502
31. Fredholm BB, IJzerman AP, Jacobson KA, Linden J, Müller CE (2011) International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors—an update. Pharmacol Rev 63(1):1–34
32. Ballesteros J, Kitanovic S, Guarnieri F, Davies P, Fromme BJ, Konvicka K, Chi L, Millar RP, Davidson JS, Weinstein H (1998) Functional microdomains in G-protein-coupled receptors the conserved arginine-cage motif in the gonadotropin-releasing hormone receptor. Journal of Biological Chemistry 273(17):10445–10453
33. Ballesteros JA, Weinstein H (1995) Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods in neurosciences 25:366–428
34. Bae H, Cabrera-Vera TM, Depree KM, Graber SG, Hamm HE (1999) Two amino acids within the α4 helix of Gαi1 mediate coupling with 5-hydroxytryptamine1B receptors. Journal of Biological Chemistry 274(21):14963–14971
35. Bae H, Anderson K, Flood LA, Skiba NP, Hamm HE, Graber SG (1997) Molecular determinants of selectivity in 5-hydroxytryptamine1B receptor-G protein interactions. Journal of Biological Chemistry 272(51):32071–32077
36. Taylor JM, Jacob-Mosier GG, Lawton RG, Remmers AE, Neubig RR (1994) Binding of an alpha 2 adrenergic receptor third intracellular loop peptide to G beta and the amino terminus of G alpha. Journal of Biological Chemistry 269(44):27618–27624
37. Blahos J, Mary S, Perroy J, de Colle C, Brabet I, Bockaert J, Pin J-P (1998) Extreme C terminus of G protein α-subunits contains a site that discriminates between Gi-coupled metabotropic glutamate receptors. Journal of Biological Chemistry 273(40):25765–25769
38. Kling RC, Lanig H, Clark T, Gmeiner P (2013) Active-state models of ternary GPCR complexes: determinants of selective receptor-G-protein coupling. PLOS ONE 8(6):e67244
39. Thimm D, Schiedel AC, Sherbiny FF, Hinz S, Hochheiser K, Bertarelli DC, Maaß A, Müller CE (2013) Ligand-specific binding and activation of the human adenosine A2B receptor. Biochemistry 52(4):726–740
40. Vroling B, Sanders M, Baakman C, Borrmann A, Verhoeven S, Klomp J, Oliveira L, de Vlieg J, Vriend G (2011) GPCRDB: information system for G protein-coupled receptors. Nucleic acids research 39(suppl 1):D309–D319
41. Vogel R, Mahalingam M, Lüdeke S, Huber T, Siebert F, Sakmar TP (2008) Functional role of the “ionic lock”—an interhelical hydrogen-bond network in family A heptahelical receptors. Journal of molecular biology 380(4):648–655
42. Scheer A, Fanelli F, Costa T, De Benedetti P, Cotecchia S (1996) Constitutively active mutants of the alpha 1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation. EMBO J 15(14):3566
43. Flanagan CA (2005) A GPCR that is not “DRY”. Molecular pharmacology 68(1):1–3
44. Chen A, Gao Z-G, Barak D, Liang BT, Jacobson KA (2001) Constitutive activation of A3 adenosine receptors by site-directed mutagenesis. Biochemical and biophysical research communications 284(3):596–601
45. Schneider EH, Schnell D, Strasser A, Dove S, Seifert R (2010) Impact of the DRY motif and the missing “ionic lock” on constitutive activity and G-protein coupling of the human histamine H4 receptor. Journal of Pharmacology and Experimental Therapeutics 333(2):382–392
46. Scheer A, Costa T, Fanelli F, De Benedetti PG, Mhaouty-Kodja S, Abuin L, Nenniger-Tosato M, Cotecchia S (2000) Mutational analysis of the highly conserved arginine within the Glu/Asp-Arg-Tyr motif of the α1b-adrenergic receptor: effects on receptor isomerization and activation. Molecular pharmacology 57(2):219–231
47. Högger P, Shockley MS, Lameh J, Sadée W (1995) Activating and inactivating mutations in N- and C-terminal i3 loop junctions of muscarinic acetylcholine Hm1 receptors. Journal of Biological Chemistry 270(13):7405–7410
48. Doré AS, Robertson N, Errey JC, Ng I, Hollenstein K, Tehan B, Hurrell E, Bennett K, Congreve M, Magnani F (2011) Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine. Structure 19(9):1283–1293
49. Simon MI, Strathmann MP, Gautam N (1991) Diversity of G proteins in signal transduction. Science 252(5007):802–808